VTAL — Justera Health Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Justera Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 13 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 21.2 | 14.7 | 1.91 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 2.7 | 2.58 | 0.857 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.052 | 0.072 | 31.4 | 19.9 | 5.07 |
| Operating Profit | -0.052 | -0.072 | -10.2 | -5.25 | -3.15 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.052 | -0.072 | -10.2 | -5.25 | -3.02 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.052 | -0.072 | -10.2 | -5.25 | -2.98 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.052 | -0.072 | -10.2 | -5.25 | -2.98 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.052 | -0.072 | -10.2 | -5.25 | -2.98 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.002 | -0.118 | -0.045 | -0.027 |
| Dividends per Share |